The anti‐CD38 antibodies, Isa, daratumumab, and MOR202 kill CD38+ lymphoma cells via antibody‐dependent cellular cytotoxicity and antibody‐dependent cellular phagocytosis9, 16, 17 In addition, Isa has strong anti‐apoptotic activity in lymphoma cells in the absence of crosslinking agents.17 Here, ANXA13 is linked to lymphoma.